{"id":"controlled-release-morphine","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Nausea"},{"rate":"20-30","effect":"Drowsiness"},{"rate":"10-20","effect":"Dizziness"},{"rate":"10-15","effect":"Vomiting"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Physical dependence"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Morphine is a mu-opioid receptor agonist that modulates pain signaling by binding to opioid receptors in the brain, spinal cord, and peripheral tissues. The controlled-release formulation provides sustained drug delivery over an extended period, allowing for less frequent dosing compared to immediate-release formulations. This mechanism produces analgesia, sedation, and other opioid effects through activation of inhibitory pathways that reduce pain transmission.","oneSentence":"Morphine binds to opioid receptors in the central and peripheral nervous system to reduce pain perception and provide analgesia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:12.932Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe chronic pain"},{"name":"Cancer pain"},{"name":"Post-operative pain"}]},"trialDetails":[{"nctId":"NCT06423703","phase":"PHASE3","title":"A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy","status":"COMPLETED","sponsor":"Tris Pharma, Inc.","startDate":"2024-07-18","conditions":"Acute Pain","enrollment":240},{"nctId":"NCT07348627","phase":"PHASE3","title":"Opioid-Sparing Joint Replacement","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Pain Management, Opioid Consumption","enrollment":120},{"nctId":"NCT03756961","phase":"NA","title":"Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2019-05-01","conditions":"Obesity, Pain, Postoperative","enrollment":220},{"nctId":"NCT06271668","phase":"","title":"Clinical Decision Support to Improve System Naloxone Co-prescribing","status":"ENROLLING_BY_INVITATION","sponsor":"University of Colorado, Denver","startDate":"2024-07-01","conditions":"Medication Abuse, Harm Reduction, Opioid Overdose","enrollment":200000},{"nctId":"NCT07251270","phase":"NA","title":"Effect of Stress Ball During Chest Tube Removal After Open Heart Surgery","status":"RECRUITING","sponsor":"Mersin University","startDate":"2025-11-27","conditions":"Pain, Hemodynamic Changes, Anxiety","enrollment":46},{"nctId":"NCT04925882","phase":"NA","title":"Erector Spinae Plane Block in Lumbar Release Surgery","status":"COMPLETED","sponsor":"Clinique Saint Jean, France","startDate":"2022-01-03","conditions":"Hernia Lumbar, Lumbar Canal Stenosis, Spinal Cord Compression","enrollment":100},{"nctId":"NCT06434233","phase":"PHASE4","title":"Opioid Use After Laparoscopic Salpingectomy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-04-25","conditions":"Opioid Use, Post-operative Pain, Sterility, Female","enrollment":120},{"nctId":"NCT07158476","phase":"PHASE4","title":"Efficacy of Methylprednisolone for Pain Control After ACL Repair","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2025-10-21","conditions":"ACL Surgery, Pain Management","enrollment":90},{"nctId":"NCT03823534","phase":"PHASE3","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2019-02-20","conditions":"Bone Metastases, Lymphoma, Multiple Myeloma","enrollment":60},{"nctId":"NCT05842044","phase":"PHASE2","title":"NSAID Use After Robotic Partial Nephrectomy","status":"RECRUITING","sponsor":"University of Miami","startDate":"2023-09-15","conditions":"Kidney Cancer, Renal Cancer, Renal Neoplasm","enrollment":110},{"nctId":"NCT07001709","phase":"PHASE4","title":"Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)","status":"RECRUITING","sponsor":"Deventer Ziekenhuis","startDate":"2024-04-12","conditions":"Prostate Cancer, Pain Cancer","enrollment":29},{"nctId":"NCT04785768","phase":"PHASE3","title":"IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration","status":"COMPLETED","sponsor":"Fujian Cancer Hospital","startDate":"2021-07-01","conditions":"Cancer Pain","enrollment":1372},{"nctId":"NCT05009771","phase":"","title":"Postoperative Pain Management of Caesarean Section","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-02-23","conditions":"Postoperative Pain, Caesarean Section, Analgesia","enrollment":100},{"nctId":"NCT06908213","phase":"NA","title":"Multicentric Evaluation of Enhanced Recovery After Surgery Protocol in Adolescent Idiopathic Scoliosis Surgery","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-05-01","conditions":"Idiopathic Scoliosis","enrollment":316},{"nctId":"NCT06864312","phase":"PHASE4","title":"Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery","status":"COMPLETED","sponsor":"University College Cork","startDate":"2023-10-16","conditions":"Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar), Ankle Fracture - Lateral Malleolus, Ankle Fracture - Medial Malleolus","enrollment":120},{"nctId":"NCT03987022","phase":"PHASE4","title":"ICE-T Pain Regimen for Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"MetroHealth Medical Center","startDate":"2019-08-01","conditions":"Opioid Substitution Treatment","enrollment":66},{"nctId":"NCT03990038","phase":"NA","title":"Comparison of Two Multimodal Analgesia Regimens in Total Knee Arthroplasty","status":"TERMINATED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2019-08-01","conditions":"Postoperative Pain","enrollment":2},{"nctId":"NCT04837014","phase":"NA","title":"Eliminating Narcotic Prescriptions from Outpatient Minimally Invasive Gynecologic Surgery","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-07-04","conditions":"Pain, Postoperative, Opioid Use","enrollment":110},{"nctId":"NCT05567354","phase":"PHASE1","title":"A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-06-10","conditions":"Recreational Drug Use","enrollment":27},{"nctId":"NCT05571345","phase":"PHASE1","title":"A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-10-05","conditions":"Recreational Drug Use","enrollment":32},{"nctId":"NCT03944005","phase":"NA","title":"Comparing Two Regional Anesthesia Interventions for Knee Arthroplasty.","status":"WITHDRAWN","sponsor":"Western University, Canada","startDate":"2020-07","conditions":"Knee Arthroplasty","enrollment":""},{"nctId":"NCT05363436","phase":"PHASE4","title":"Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed","status":"SUSPENDED","sponsor":"Thomas Jefferson University","startDate":"2018-01-01","conditions":"Opioid Abuse, Opioid Misuse, Pain","enrollment":159},{"nctId":"NCT06227208","phase":"","title":"Postoperative Opioid and Respiratory Depression in Opioid Naive and Chronic Opioid Patients","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2023-10-01","conditions":"Medical Complication","enrollment":691},{"nctId":"NCT00226395","phase":"PHASE3","title":"Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2004-09","conditions":"Acute Pain","enrollment":320},{"nctId":"NCT04515953","phase":"PHASE1","title":"A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340)","status":"SUSPENDED","sponsor":"Nang Kuang Pharmaceutical Co., Ltd.","startDate":"2020-10-15","conditions":"Pain, Postoperative","enrollment":36},{"nctId":"NCT04429022","phase":"PHASE3","title":"Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2020-11-24","conditions":"Pain, Postoperative","enrollment":68},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT05327777","phase":"PHASE4","title":"Toward Zero Prescribed Opioids for Outpatient General Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2019-11-01","conditions":"Opioid Misuse and Addiction, Pain","enrollment":129},{"nctId":"NCT04429516","phase":"PHASE3","title":"Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough","status":"COMPLETED","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2020-12-17","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":44},{"nctId":"NCT01081912","phase":"PHASE3","title":"Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Zogenix, Inc.","startDate":"2010-03","conditions":"Back Pain Lower Back Chronic","enrollment":510},{"nctId":"NCT02197156","phase":"PHASE2","title":"A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery","status":"COMPLETED","sponsor":"Zogenix, Inc.","startDate":"2002-08","conditions":"Postoperative Pain","enrollment":241},{"nctId":"NCT02242734","phase":"PHASE1","title":"Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic Impairment","status":"COMPLETED","sponsor":"Zogenix, Inc.","startDate":"2011-02","conditions":"Hepatic Impairment","enrollment":30},{"nctId":"NCT01115569","phase":"PHASE3","title":"Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain","status":"COMPLETED","sponsor":"Zogenix, Inc.","startDate":"2010-05","conditions":"Chronic Pain","enrollment":424},{"nctId":"NCT02939209","phase":"PHASE4","title":"Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair and/or Acromioplasty Under General Anesthesia and Interscalene Block","status":"COMPLETED","sponsor":"Vishal Uppal","startDate":"2017-04-20","conditions":"Rotator Cuff Injury, Pain","enrollment":73},{"nctId":"NCT01740492","phase":"PHASE1","title":"Low Dose Ketamine for Management of Acute Severe Pain in the Emergency Department","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2012-09","conditions":"Pain","enrollment":75},{"nctId":"NCT03471442","phase":"NA","title":"Erector Spinae Plane Block Versus Paravertebral Block","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2018-05-29","conditions":"Breast Cancer, Pain, Postoperative, Anesthesia, Local","enrollment":48},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT02487108","phase":"PHASE3","title":"Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-08-11","conditions":"Pain","enrollment":569},{"nctId":"NCT03670160","phase":"PHASE2","title":"Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of Tennessee Medical Center","startDate":"2018-10-01","conditions":"Neonatal Abstinence Syndrome","enrollment":25},{"nctId":"NCT02687451","phase":"PHASE3","title":"Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects","status":"TERMINATED","sponsor":"Endo Pharmaceuticals","startDate":"2016-04","conditions":"Post-Operative Pain, Acute Pain","enrollment":28},{"nctId":"NCT02351700","phase":"PHASE4","title":"Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2015-02-01","conditions":"Pituitary Tumor, Pain","enrollment":62},{"nctId":"NCT02740114","phase":"PHASE3","title":"Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-08-31","conditions":"Malignant Neoplasms of Female Genital Organs, Gynecologic Cancer","enrollment":105},{"nctId":"NCT03586934","phase":"PHASE3","title":"Multimodal Analgesia in Shoulder Arthroplasty","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2018-06-01","conditions":"Shoulder Pain, Opioid Use","enrollment":""},{"nctId":"NCT03757559","phase":"PHASE1","title":"A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users","status":"COMPLETED","sponsor":"Tris Pharma, Inc.","startDate":"2013-04-15","conditions":"Abuse, Drug","enrollment":226},{"nctId":"NCT03175653","phase":"NA","title":"Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control","status":"WITHDRAWN","sponsor":"Mount Carmel Health System","startDate":"2017-06-16","conditions":"Post-operative Pain Control","enrollment":""},{"nctId":"NCT01500109","phase":"NA","title":"Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2011-11","conditions":"Cleft Palate","enrollment":45},{"nctId":"NCT02514252","phase":"PHASE2","title":"Sublingual Fentanyl for the Management of Breakthrough Pain","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-02-02","conditions":"Advanced Cancers","enrollment":6},{"nctId":"NCT03296345","phase":"PHASE2","title":"Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis","status":"COMPLETED","sponsor":"UCSF Benioff Children's Hospital Oakland","startDate":"2016-06","conditions":"Sickle Cell Disease, Vaso-Occlusive Crisis","enrollment":62},{"nctId":"NCT04243954","phase":"PHASE2","title":"Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration","status":"COMPLETED","sponsor":"Fujian Cancer Hospital","startDate":"2020-04-10","conditions":"Cancer Pain","enrollment":95},{"nctId":"NCT01205516","phase":"PHASE4","title":"Methadone in Neuropathic Pain","status":"TERMINATED","sponsor":"Nova Scotia Health Authority","startDate":"2013-01","conditions":"Chronic Neuropathic Pain","enrollment":14},{"nctId":"NCT03945578","phase":"NA","title":"Effects of Visceral Manipulation in Women With Urinary Incontinence","status":"COMPLETED","sponsor":"University of the State of Santa Catarina","startDate":"2019-07-01","conditions":"Urinary Incontinence","enrollment":52},{"nctId":"NCT02659501","phase":"NA","title":"Liposomal Bupivacaine in Implant Based Breast Reconstruction","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2015-07","conditions":"Breast Cancer, Postoperative Pain","enrollment":24},{"nctId":"NCT04692571","phase":"EARLY_PHASE1","title":"EMG-Based Hand-Wrist Control: Study B Mirrored","status":"COMPLETED","sponsor":"Liberating Technologies, Inc.","startDate":"2017-06-29","conditions":"Amputation, Amputation; Traumatic, Hand, Amputation, Congenital","enrollment":20},{"nctId":"NCT01906073","phase":"PHASE3","title":"Nasal Fentanyl for Chronic Cancer Pain","status":"WITHDRAWN","sponsor":"Norwegian University of Science and Technology","startDate":"2017-01","conditions":"Cancer, Pain","enrollment":""},{"nctId":"NCT04635852","phase":"PHASE2","title":"Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2013-03","conditions":"Cancer, Dyspnea, Paroxysmal","enrollment":10},{"nctId":"NCT03248765","phase":"","title":"Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2017-08-30","conditions":"Pain, Chronic, Opioid Use","enrollment":10},{"nctId":"NCT03809182","phase":"PHASE4","title":"Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2012-09-27","conditions":"Bariatric Surgery Candidate, Glucose Intolerance, Insulin Resistance","enrollment":40},{"nctId":"NCT04549818","phase":"NA","title":"Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-09-10","conditions":"Chronic Pain","enrollment":44},{"nctId":"NCT04533243","phase":"PHASE3","title":"Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain","status":"UNKNOWN","sponsor":"Fujian Cancer Hospital","startDate":"2020-09-01","conditions":"Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive","enrollment":209},{"nctId":"NCT03845881","phase":"EARLY_PHASE1","title":"Trial Comparing a Multi-Modal Pain Protocol With and Without Opioids Following Total Joint Arthroplasty","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-04-10","conditions":"Total Knee Arthroplasty","enrollment":45},{"nctId":"NCT04292990","phase":"PHASE4","title":"Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients","status":"UNKNOWN","sponsor":"Jiarong Chen, MD","startDate":"2020-12","conditions":"Pain, Nasopharyngeal Carcinoma, Head and Neck Cancer","enrollment":300},{"nctId":"NCT02101554","phase":"PHASE4","title":"Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain","status":"TERMINATED","sponsor":"Pfizer","startDate":"2015-04-24","conditions":"Moderate-severe Pain","enrollment":19},{"nctId":"NCT04448457","phase":"NA","title":"Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Tivoli","startDate":"2017-09-01","conditions":"Postoperative Pain","enrollment":72},{"nctId":"NCT00880607","phase":"PHASE4","title":"Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-12","conditions":"Pain Management, Spinal Fusion, Scoliosis","enrollment":84},{"nctId":"NCT04132011","phase":"PHASE4","title":"Dosing Intervals of Opioid Medication for Chronic Pain","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2019-05-01","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT03570320","phase":"NA","title":"Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?","status":"COMPLETED","sponsor":"John Yanik","startDate":"2018-09-04","conditions":"Opioid Use","enrollment":48},{"nctId":"NCT04308525","phase":"","title":"Optimising Microsurgical Reconstruction After Advanced Head and Neck Cancers","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-01","conditions":"Head and Neck Cancer","enrollment":25},{"nctId":"NCT01192295","phase":"PHASE3","title":"Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2010-11","conditions":"Pain","enrollment":155},{"nctId":"NCT03176121","phase":"PHASE4","title":"Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-10-31","conditions":"Cancer, Pain","enrollment":73},{"nctId":"NCT03176199","phase":"PHASE4","title":"A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-09-01","conditions":"Cancer, Pain","enrollment":30},{"nctId":"NCT01705288","phase":"EARLY_PHASE1","title":"Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2013-01-01","conditions":"Cervical Cancer, Uterine Endometrial Cancer, Ovarian Cancer","enrollment":103},{"nctId":"NCT02720822","phase":"PHASE3","title":"Breathlessness Exertion and Morphine Sulphate","status":"COMPLETED","sponsor":"Flinders University","startDate":"2016-08-08","conditions":"Chronic Obstructive Pulmonary Disease, Dyspnea","enrollment":171},{"nctId":"NCT03275012","phase":"PHASE2","title":"Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain","status":"WITHDRAWN","sponsor":"Pharmaceutical Research Management srl","startDate":"2017-04-04","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT00472303","phase":"PHASE3","title":"A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-07","conditions":"Tumor, Pain","enrollment":622},{"nctId":"NCT00505414","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine","status":"TERMINATED","sponsor":"Grünenthal GmbH","startDate":"2007-06","conditions":"Pain, Neoplasm, Cancer","enrollment":136},{"nctId":"NCT00478023","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-05","conditions":"Hysterectomy, Postoperative","enrollment":854},{"nctId":"NCT03478423","phase":"NA","title":"Opioid Analgesics for Acute Fracture Pain in Adults Discharged From the ED","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2018-02-05","conditions":"Acute Pain","enrollment":5},{"nctId":"NCT02429050","phase":"PHASE4","title":"Morphine for Treatment of Dyspnea in Patients With COPD","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2016-11-16","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":124},{"nctId":"NCT04003350","phase":"NA","title":"The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Rothman Institute Orthopaedics","startDate":"2017-12-21","conditions":"Osteo Arthritis Knee","enrollment":216},{"nctId":"NCT03996564","phase":"NA","title":"Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department","status":"COMPLETED","sponsor":"San Antonio Military Medical Center","startDate":"2016-02-22","conditions":"Low Back Pain, Mechanical","enrollment":26},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT01503528","phase":"PHASE4","title":"Motor Sparing Block vs. Peri-Articular Catheters","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2017-10-16","conditions":"Knee Joint Arthritis, Knee Joint Arthroplasty","enrollment":54},{"nctId":"NCT02132416","phase":"NA","title":"Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2014-05","conditions":"Trauma, Flail Chest, Rib Fractures","enrollment":92},{"nctId":"NCT00743587","phase":"PHASE1","title":"A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Osteoarthritis Thumbs","enrollment":36},{"nctId":"NCT00513656","phase":"PHASE2","title":"A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2007-09","conditions":"Cancer, Pain, Constipation","enrollment":230},{"nctId":"NCT01971632","phase":"PHASE3","title":"A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2005-01","conditions":"Subjects With Moderate to Severe, Chronic Nonmalignant Pain","enrollment":463},{"nctId":"NCT03088306","phase":"EARLY_PHASE1","title":"Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-07-01","conditions":"Lumbar Spinal Stenosis, Lumbar Spinal Instability, Lumbar Spine Degeneration","enrollment":49},{"nctId":"NCT01677065","phase":"","title":"A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-09","conditions":"Healthy","enrollment":14},{"nctId":"NCT02680847","phase":"PHASE4","title":"Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain","status":"TERMINATED","sponsor":"Pfizer","startDate":"2016-01-21","conditions":"Moderate-severe Pain","enrollment":32},{"nctId":"NCT00934661","phase":"PHASE4","title":"Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing","status":"TERMINATED","sponsor":"Wake Forest University","startDate":"2010-01","conditions":"Hip Arthroplasty","enrollment":40},{"nctId":"NCT00955877","phase":"NA","title":"Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2010-03","conditions":"Spastic Cerebral Palsy","enrollment":13},{"nctId":"NCT03475862","phase":"PHASE1","title":"Nasal Human Abuse Potential of PTI-821","status":"COMPLETED","sponsor":"Pain Therapeutics","startDate":"2017-05-15","conditions":"Opioid Abuse Nondependent","enrollment":38},{"nctId":"NCT01631513","phase":"PHASE4","title":"An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)","status":"WITHDRAWN","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2012-08","conditions":"Pain, Chronic Back Pain, Chronic Low Back Pain","enrollment":""},{"nctId":"NCT00994383","phase":"NA","title":"Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2007-01","conditions":"Pain","enrollment":36},{"nctId":"NCT00955110","phase":"PHASE4","title":"Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2009-06","conditions":"Healthy","enrollment":78},{"nctId":"NCT00679614","phase":"PHASE3","title":"Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2007-12-17","conditions":"Hip Arthroplasty, Knee Arthroplasty, Spinal Anesthesia","enrollment":45},{"nctId":"NCT01571362","phase":"PHASE3","title":"A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-06","conditions":"Chronic Pain, Low Back Pain, Analgesia","enrollment":410},{"nctId":"NCT01686802","phase":"PHASE2","title":"Post-operative Oral Morphine Versus Ibuprofen","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-09","conditions":"Post-operative Pain","enrollment":132},{"nctId":"NCT02641301","phase":"PHASE4","title":"Sustained-release Morphine Pharmacokinetics in Roux-en-Y Gastric Bypass Subjects","status":"UNKNOWN","sponsor":"Hopital Lariboisière","startDate":"2015-12","conditions":"Bypass Complications","enrollment":24},{"nctId":"NCT02208219","phase":"NA","title":"Music Therapy to Restore Motor Deficits After Stroke","status":"UNKNOWN","sponsor":"University of Barcelona","startDate":"2013-11","conditions":"Stroke, Paresis","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":124,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Controlled Release Morphine","genericName":"Controlled Release Morphine","companyName":"Nova Scotia Health Authority","companyId":"nova-scotia-health-authority","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Morphine binds to opioid receptors in the central and peripheral nervous system to reduce pain perception and provide analgesia. Used for Moderate to severe chronic pain, Cancer pain, Post-operative pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}